FAMOTIDINE, THE NEW ANTIULCERO-GENIC AGENT, A POTENT LIGAND FOR METAL-IONS

被引:13
作者
KOZLOWSKI, H
KOWALIKJANKOWSKA, T
ANOUAR, A
DECOCK, P
SPYCHALA, J
SWIATEK, J
GANADU, ML
机构
[1] UNIV LILLE 1, CHIM ORGAN & ENVIRONNEMENT LAB, F-59655 VILLENEUVE DASCQ, FRANCE
[2] MED ACAD WROCLAW, DEPT BASIC MED SCI, PL-50367 WROCLAW, POLAND
[3] UNIV SASSARI, DIPARTIMENTO CHIM, I-07100 SASSARI, ITALY
关键词
D O I
10.1016/0162-0134(92)84034-K
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Potentiometric, polarographic, and spectroscopic results obtained for Cu2+ and Ni2+-famotidine systems clearly indicated that this anti-ulcerogenic drug is a very potent chelating agent able to coordinate cupric ion that was at pH below 2. This drug exhibits excellent histamine H-2 receptor blocking effects and its effective coordination to metal ions may have significant biological implications. Famotidine is found to be a very effective ligand for Ni2+ ions also.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 17 条
[1]   AN ASSESSMENT OF THE PHYSIOLOGICAL SIGNIFICANCE OF CIMETIDINE INTERACTIONS WITH COPPER AND ZINC IN BIOFLUIDS AS BASED ON THE COMPUTER-SIMULATED DISTRIBUTION OF THE INVOLVED COMPLEXES AT THERAPEUTIC LEVELS OF THE DRUG [J].
AKRIVOS, F ;
BLAIS, MJ ;
HOFFELT, J ;
BERTHON, G .
AGENTS AND ACTIONS, 1984, 15 (5-6) :649-659
[2]   HISTAMINE H-2 RECEPTORS IN RAT RENAL GLOMERULI [J].
CHANSEL, D ;
OUDINET, JP ;
NIVEZ, MP .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (03) :367-375
[3]   THE DETERMINATION OF CONSECUTIVE FORMATION CONSTANTS OF COMPLEX IONS FROM POLAROGRAPHIC DATA [J].
DEFORD, DD ;
HUME, DN .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1951, 73 (11) :5321-5322
[4]   BIOLOGICAL SIGNIFICANCE OF CIMETIDINE SULFOXIDE COMPLEXES WITH COPPER(II) AND ZINC(II) IONS DURING CIMETIDINE TREATMENT [J].
FREIJANES, E ;
BERTHON, G .
INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1986, 124 (03) :141-147
[5]  
Ganellin CR, 1982, PHARM HISTAMINE RECE
[6]   SUPERQUAD - AN IMPROVED GENERAL PROGRAM FOR COMPUTATION OF FORMATION-CONSTANTS FROM POTENTIOMETRIC DATA [J].
GANS, P ;
SABATINI, A ;
VACCA, A .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1985, (06) :1195-1200
[7]   COPPER(II) COMPLEXES OF THE ANTI-ULCER DRUG CIMETIDINE [J].
GREENAWAY, FT ;
BROWN, LM ;
DABROWIAK, JC ;
THOMPSON, MR ;
DAY, VM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1980, 102 (26) :7782-7784
[8]   COMPARISON OF THE POLYMORPHIC MODIFICATIONS OF FAMOTIDINE [J].
HEGEDUS, B ;
BOD, P ;
HARSANYI, K ;
PETER, I ;
KALMAN, A ;
PARKANYI, L .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1989, 7 (05) :563-569
[9]   A STUDY OF SOME PROBLEMS IN DETERMINING STOICHEIOMETRIC PROTON DISSOCIATION CONSTANTS OF COMPLEXES BY POTENTIOMETRIC TITRATIONS USING A GLASS ELECTRODE [J].
IRVING, HM ;
MILES, MG ;
PETTIT, LD .
ANALYTICA CHIMICA ACTA, 1967, 38 (04) :475-+
[10]   ELEVATION OF [H-3] CIMETIDINE BINDING BY CUCL2 IN BRAIN MEMBRANES OF RATS [J].
KAWAI, M ;
NOMURA, Y ;
SEGAWA, T .
NEUROCHEMISTRY INTERNATIONAL, 1984, 6 (04) :563-568